why choose us

First received: August 08, 2022

Clinical Trial: A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: Early Alzheimer's Disease

Study Type: INTERVENTIONAL


Official Title: Synaptic Therapy Alzheimer's Research Trial (START): A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's D

Brief Summary: This is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's disease.

Read more